Accenture is a global professional services company operating in the business services industry.
Defined by its expertise in technology and consulting, the firm's core strength lies in delivering innovative digital transformation and outsourcing solutions to a broad range of clients worldwide.
Updated: February 18, 2026, 16:00 EST
ACN is experiencing significant technical weakness, trading near 52-week lows after declining sharply over multiple timeframes. The stock appears deeply oversold with a 43.9% drop from its high, suggesting potential for a technical rebound if market sentiment improves. However, its higher volatility compared to the market (beta of 1.236) indicates continued susceptibility to broad market swings.
The company maintains strong fundamentals with solid revenue growth and improving profitability margins. ACN's financial health is robust, featuring low debt levels, strong interest coverage, and healthy liquidity ratios. Operational efficiency metrics remain solid, though moderate asset turnover suggests potential for improvement in capital utilization.
ACN appears reasonably valued based on its forward P/E of 18.0, while the compelling PEG ratio of 0.31 indicates potential undervaluation relative to growth prospects. However, the elevated EV/EBITDA of 46.3 warrants caution, signaling the market may be pricing in high expectations for future cash flow generation.
Primary risks include ACN's higher volatility profile and sensitivity to economic cycles affecting corporate IT spending. The significant maximum drawdown of -43.65% underscores the stock's vulnerability during market downturns. While short interest remains low, sector-wide pressures on consulting budgets persist as key concerns.
Consider Buying - ACN presents a compelling opportunity amid current oversold conditions, supported by strong fundamentals and reasonable valuation metrics. The stock's significant decline appears overdone relative to its solid financial health and growth prospects. Investors with medium-to-long-term horizons could benefit from potential recovery, though should be prepared for near-term volatility given the stock's sensitivity to economic conditions.
*This analysis is for informational purposes only and does not constitute investment advice. Investors should conduct their own research before making any investment decisions.*
Based on a 12-month outlook, ACN is poised for a potential recovery driven by attractive valuation and oversold technical conditions, though the path will likely be volatile.
The key catalysts for a rebound are the compelling valuation (notably the PEG ratio of 0.31 suggesting undervaluation) and the stock's deeply oversold status after a 44% decline from its highs, which appears overdone given the company's solid revenue growth and robust financial health. Primary risks include the stock's high beta (1.236), making it susceptible to broader market swings, and persistent sector-wide pressures on corporate IT and consulting budgets if economic growth slows. Given the absence of a specific analyst target, the potential for a technical bounce-back suggests a reasonable target range could be $250-$280, contingent on a stabilization in market sentiment and no significant deterioration in the economic outlook.
Most Wall Street analysts are optimistic about Accenture plc's 12-month outlook, with consensus target around $223.61, indicating expected upside potential.
Overall, ACN has investment potential but also faces challenges. Here are key factors to weigh before investing.
ACN has experienced significant downward pressure over the past year, with the stock currently trading near its 52-week low amid substantial declines.
Over the past month, ACN has declined sharply by 23.59%, significantly underperforming the market by over 9% during the last three months; its beta of 1.236 indicates higher volatility than the broader market, which has amplified recent losses. The three-month decline of 9.35% further confirms this pronounced weak trend versus market benchmarks.
Currently trading at $219.89, ACN sits just above its 52-week low of $215.16, having fallen 43.9% from its 52-week high of $392.02; this extreme drawdown of -43.65% over the past year positions the stock in deeply oversold territory, suggesting potential for a technical rebound absent further negative catalysts.
| Period | ACN Return | S&P 500 |
|---|---|---|
| 1m | -21.9% | -0.8% |
| 3m | -9.3% | +0.4% |
| 6m | -6.3% | +7.9% |
| 1y | -42.7% | +12.0% |
| ytd | -14.0% | +0.5% |
Revenue & Profitability ACN demonstrates solid revenue growth with quarterly revenue increasing from $17.6B to $18.7B quarter-over-quarter. The company maintains strong profitability with a net profit margin of 11.8% in Q1 2026, showing improvement from the previous quarter's 8.0%. Operating income ratio expanded significantly from 11.6% to 16.8%, indicating enhanced operational efficiency.
Financial Health The company maintains excellent financial health with a conservative debt ratio of 12.7% and a robust interest coverage ratio of 48.2x. A strong current ratio of 1.41 and cash ratio of 0.48 provide ample liquidity, while the cash flow to debt ratio of 0.20 indicates sufficient cash generation to service obligations.
Operational Efficiency ACN exhibits solid operational efficiency with a return on equity of 7.2% and return on assets of 3.4%. The asset turnover of 0.29 reflects moderate asset utilization efficiency, while the cash conversion cycle of 56 days demonstrates effective working capital management. Fixed asset turnover of 4.34 indicates efficient utilization of long-term assets.
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Try Now & Get Tesla Stock RewardBased on the forward P/E of 18.0, ACN appears reasonably valued. This multiple suggests the market prices the stock in line with its near-term earnings expectations. The PEG ratio of approximately 0.31 is particularly compelling, indicating the stock may be undervalued relative to its projected earnings growth rate, though the elevated EV/EBITDA of 46.3 warrants attention as it signals a high valuation on a cash flow basis when including debt.
A direct peer comparison is not feasible as industry average data is unavailable. However, ACN's valuation metrics must be assessed independently. The discrepancy between the seemingly reasonable P/E and the high EV/EBITDA suggests the company's capital structure or non-operating items significantly impact its overall enterprise value, meriting a more nuanced analysis than a standard peer benchmark would provide.
Volatility Risk: ACN's beta of 1.236 indicates the stock is moderately more volatile than the broader market, suggesting it may experience larger price swings. This is corroborated by a significant one-year maximum drawdown of -43.65%, highlighting substantial downside risk during market downturns. An investor should be prepared for periods of notable price depreciation.
Other Risks: The absence of meaningful short interest suggests a market consensus that the stock is not significantly overvalued or facing major fundamental headwinds. However, despite favorable sentiment, broader macroeconomic risks affecting the consulting and IT services sector, such as reduced corporate spending, remain the primary concern.
Bullish. ACN presents a compelling opportunity for long-term, value-oriented investors seeking AI exposure.
Reasons: 1. Strong Fundamental Momentum: The company is demonstrating solid revenue growth, expanding profitability, and excellent financial health, providing a stable foundation. 2. Strategic AI Positioning: Significant AI-related bookings and a major partnership with OpenAI underscore a clear path for future growth and industry leadership. 3. Attractive Valuation: The stock is deeply oversold and trades near 52-week lows, while its PEG ratio suggests it is undervalued relative to its earnings growth potential.
Suitable for: Patient, long-term investors and those with a value-investing approach who can tolerate near-term volatility (indicated by its high beta).
Based on the provided metrics, ACN appears fairly valued to slightly undervalued. The core P/E ratio of 18.1 and forward P/E of 18.0 are reasonable for a high-quality company. The most compelling signal for potential undervaluation is the PEG ratio of 0.31, which is significantly below 1 and suggests the stock price does not fully reflect its earnings growth prospects. This is supported by strong fundamentals, including improving profit margins and excellent financial health. However, the high Price-to-Book (4.32) and EV/EBITDA ratios indicate the market already prices in a premium for its sturdy brand and consistent performance.
Based on the provided information, here are 3 key risks of holding ACN stock, ordered by importance:
1. Market and Macroeconomic Risk: The primary risk is that macroeconomic pressures, such as reduced corporate spending on IT and consulting services, could significantly impact ACN's future revenue and profitability, as evidenced by the stock's recent sharp decline and its high sensitivity to market downturns (beta of 1.236). 2. High Volatility and Downside Risk: The stock exhibits substantial price volatility and downside risk, characterized by a significant 52-week maximum drawdown of -43.65% and a high beta, meaning it can experience larger losses than the broader market during downturns. 3. Company-Specific Performance Risk: Despite strong financial health, ACN faces a specific risk related to reversing its pronounced negative price trend and restoring investor confidence after a steep 23.59% one-month decline and its current position trading near a 52-week low.
Based on the provided analysis, here is a forecast for ACN stock through 2026:
My forecast foresees a target price range of $275 - $320 by the end of 2026, with the base case anchored by ACN's solid financial health and the bull case reflecting successful execution on growth drivers. The primary catalysts are the compelling valuation (notably the PEG ratio), a potential recovery in corporate IT spending, and the company's own operational efficiency improvements. These forecasts assume a stabilization in macroeconomic conditions and no severe deterioration in client budgets, though the stock's high beta introduces significant uncertainty tied to broader market volatility.